We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
-6.95%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.11B
AUM Growth
-$244M
(-18%)
Cap. Flow
-$132M
Cap. Flow
% of AUM
-11.97%
Top 10 Holdings %
Top 10 Hldgs %
3.48%
Holding
2,176
New
618
Increased
465
Reduced
510
Closed
580
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSX Corp
CSX
|
+$4.82M |
| 2 |
Blackstone
BX
|
+$4.54M |
| 3 |
Tandem Diabetes Care
TNDM
|
+$3.82M |
| 4 |
Cal-Maine
CALM
|
+$3.17M |
| 5 |
Ziff Davis
ZD
|
+$3.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$97.2M |
| 2 |
NVIDIA
NVDA
|
+$7.97M |
| 3 |
Microsoft
MSFT
|
+$7.34M |
| 4 |
Amazon
AMZN
|
+$7.07M |
| 5 |
Costco
COST
|
+$6.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.36% |
| 2 | Financials | 14.89% |
| 3 | Technology | 13.64% |
| 4 | Consumer Discretionary | 13.03% |
| 5 | Industrials | 12.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Vir Biotechnology
VIR
$1.49B
| $119K | 0.01% |
+18,399
| New | +$164K |
|
1477
Invivyd
IVVD
$218M
| $117K | 0.01% |
192,660
-269,778
| -58% | -$242K |
|
1478
Roivant Sciences
ROIV
$26.2B
| $117K | 0.01% |
+11,644
| New | +$126K |
|
|
VIP
1479
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$37.2M
| $116K | 0.01% |
158,306
+8,519
| +6% | +$10.2K |
|
1480
Atara Biotherapeutics
ATRA
$76.1M
| $115K | 0.01% |
+19,385
| New | +$169K |
|
1481
inTEST
INTT
$177M
| $115K | 0.01% |
16,505
-3,090
| -16% | -$25.6K |
|
|
AVDL
1482
DELISTED
Avadel Pharmaceuticals
AVDL
| $114K | 0.01% |
+14,604
| New | +$122K |
|
|
DENN
1483
DELISTED
Denny's
DENN
| $114K | 0.01% |
+31,007
| New | +$163K |
|
1484
Seer Inc
SEER
$120M
| $114K | 0.01% |
67,380
-22,139
| -25% | -$48.2K |
|
1485
Ocular Therapeutix
OCUL
$2.02B
| $112K | 0.01% |
+15,306
| New | +$118K |
|
1486
Hecla Mining
HL
$11.3B
| $111K | 0.01% |
19,974
-26,161
| -57% | -$145K |
|
1487
INNOVATE Corp
VATE
$165M
| $109K | 0.01% |
+13,943
| New | +$126K |
|
1488
Cue Biopharma
CUE
$114M
| $107K | 0.01% |
3,909
-1,084
| -22% | -$40.3K |
|
|
SEPN
1489
Septerna Inc
SEPN
$1.75B
| $106K | 0.01% |
+18,299
| New | +$209K |
|
1490
Gabelli Equity Trust
GAB
$1.79B
| $105K | 0.01% |
+19,048
| New | +$105K |
|
1491
N-able
NABL
$940M
| $105K | 0.01% |
14,869
-36,617
| -71% | -$326K |
|
1492
MeiraGTx Holdings
MGTX
$1.21B
| $103K | 0.01% |
+15,237
| New | +$102K |
|
|
ALLK
1493
DELISTED
Allakos
ALLK
| $102K | 0.01% |
449,504
+3,341
| +0.7% | +$1.51K |
|
1494
Wave Life Sciences
WVE
$1.2B
| $102K | 0.01% |
+12,643
| New | +$138K |
|
1495
Zedge
ZDGE
$38.9M
| $102K | 0.01% |
+43,721
| New | +$111K |
|
|
BCYC
1496
Bicycle Therapeutics
BCYC
$292M
| $101K | 0.01% |
+11,952
| New | +$141K |
|
|
VISN
1497
Vistance Networks Inc
VISN
$2.52B
| $101K | 0.01% |
18,935
-91,727
| -83% | -$487K |
|
1498
Kaltura
KLTR
$267M
| $101K | 0.01% |
53,982
+43,979
| +440% | +$98.3K |
|
1499
Sera Prognostics
SERA
$81.1M
| $101K | 0.01% |
+27,455
| New | +$140K |
|
1500
Broadwind
BWEN
$109M
| $100K | 0.01% |
+68,856
| New | +$115K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2025 Portfolio in Review
As of Q1 2025, GSA Capital Partners held 2,176 positions worth $1.11B, down 18% from $1.35B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
GSA Capital Partners withdrew a net $132M in Q1 2025, closing 580 positions and reducing 510 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $97.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 13% a quarter earlier, followed by Financials and Technology.
Against the trend, GSA Capital Partners opened a new position in CSX Corp worth $4.46M.
- GSA Capital Partners's largest Q1 2025 buy was CSX Corp: 151,729 shares worth $4.46M.
- GSA Capital Partners added most to Blackstone in Q1 2025, an estimated $4.54M increase.
- GSA Capital Partners's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $7.97M.
- GSA Capital Partners fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $97.2M.
- GSA Capital Partners's ten largest holdings make up 3.5% of its $1.11B portfolio in Q1 2025.
- GSA Capital Partners opened 618 new positions and closed 580 in Q1 2025.
- GSA Capital Partners's portfolio value fell 18% quarter-over-quarter to $1.11B.
Based on GSA Capital Partners's 13F filing for Q1 2025, filed 8 May 2025.